DOI:
10.1055/s-00000059
Pneumologie
LinksClose Window
References
Busse WW. et al.
Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial.
Lancet Respir Med 2019;
7: 46-59
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.